Philip A. Blumenfeld

Radiation Oncology

1653 W Congress Pkwy
Chicago, IL 60612

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Beyond two rooms: proton therapy access for all.

Beyond two rooms: proton therapy access for all.

Journal: The Israel Medical Association journal : IMAJ

Published: September 06, 2026

Neoadjuvant SBRT and intraoperative electron radiotherapy in pancreatic cancer resection.

Neoadjuvant SBRT and intraoperative electron radiotherapy in pancreatic cancer resection.

Journal: Journal of cancer research and clinical oncology

Published: November 07, 2025

Daily artificial intelligence-assisted adaptive small margin radiotherapy during trimodal therapy of muscle-invasive bladder cancer.

Daily artificial intelligence-assisted adaptive small margin radiotherapy during trimodal therapy of muscle-invasive bladder cancer.

Journal: Frontiers in oncology

Published: October 21, 2025

Pediatric CNS relapse of neuroblastoma treated with upright proton craniospinal irradiation.

Pediatric CNS relapse of neuroblastoma treated with upright proton craniospinal irradiation.

Journal: Clinical and translational radiation oncology

Published: September 02, 2025

RapidPlan Knowledge-Based Radiotherapy Planning Compared to Manual Planning in Locally Advanced Non-Small-Cell Lung Cancer.

RapidPlan Knowledge-Based Radiotherapy Planning Compared to Manual Planning in Locally Advanced Non-Small-Cell Lung Cancer.

Journal: Cancers

Published: August 27, 2025

Assessment of the Effective Dose to Immune Cells as an Independent Predictor of Durvalumab Response in Patients With Non-Small Cell Lung Cancer After Chemoradiotherapy: A Multicenter Study.

Assessment of the Effective Dose to Immune Cells as an Independent Predictor of Durvalumab Response in Patients With Non-Small Cell Lung Cancer After Chemoradiotherapy: A Multicenter Study.

Journal: International journal of radiation oncology, biology, physics

Published: August 13, 2025

BRAF V600E Metastatic Synovial Sarcoma Treated with BRAF & MEK Inhibitors Achieves Complete Response. A Case Report & Literature Review.

BRAF V600E Metastatic Synovial Sarcoma Treated with BRAF & MEK Inhibitors Achieves Complete Response. A Case Report & Literature Review.

Journal: Oncology research

Published: July 11, 2025

Planning Target Volume and Nodal Status Predict Clinical Outcomes After Chemoradiation and Durvalumab in Stage III Non-Small Cell Lung Cancer.

Planning Target Volume and Nodal Status Predict Clinical Outcomes After Chemoradiation and Durvalumab in Stage III Non-Small Cell Lung Cancer.

Journal: Thoracic cancer

Published: April 23, 2025

Prospective clinical trial of upright image-guided proton therapy for locally recurrent head and neck and brain malignancies.

Prospective clinical trial of upright image-guided proton therapy for locally recurrent head and neck and brain malignancies.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: March 17, 2025

Efficacy and Safety of Metastatic Directed Treatment of Oligometastatic Disease: Results of a Meta-analysis.

Efficacy and Safety of Metastatic Directed Treatment of Oligometastatic Disease: Results of a Meta-analysis.

Journal: Advances in radiation oncology

Published: December 12, 2024

Complication Rates After Mastectomy and Reconstruction in Breast Cancer Patients Treated with Hypofractionated Radiation Therapy Compared to Conventional Fractionation: A Single Institutional Analysis.

Complication Rates After Mastectomy and Reconstruction in Breast Cancer Patients Treated with Hypofractionated Radiation Therapy Compared to Conventional Fractionation: A Single Institutional Analysis.

Journal: Cancers

Published: December 01, 2024

Predictive value of ENLIGHT-DP in patients with metastatic lung adenocarcinoma treated with immune checkpoint inhibitors and platinum chemotherapy directly from histopathology slides using inferred transcriptomics.

Predictive value of ENLIGHT-DP in patients with metastatic lung adenocarcinoma treated with immune checkpoint inhibitors and platinum chemotherapy directly from histopathology slides using inferred transcriptomics.

Journal: Journal for immunotherapy of cancer

Published: November 30, 2024

Showing 1-12 of 32

Last Updated: 09/26/2026